Rapid analytical tryptic mapping of a recombinant chimeric monoclonal antibody and method validation challenges.
A rapid and reproducible analytical tryptic mapping method was developed as an identity test for a recombinant chimeric monoclonal antibody for lot release testing. The unfolding, reduction, carboxymethylation, trypsin digestion, and reversed-phase (RP) HPLC steps were optimized to provide a reproducible method. The optimized method requires 30 min for unfolding the protein, 30 min for carboxymethylation, 4 h for digestion with TPCK-trypsin and 140 min for RPHPLC analysis. The total time required is less than 8 h compared to conventional procedures, which must be performed over several days. The optimized method was validated for its precision, recovery, specificity, and robustness. The precision of the method was determined by repeatability and intermediate precision experiments. Relative standard deviation (RSD) values were < or = 10% for the relative peak areas of marker peaks. The mean recovery of these marker peaks was 88.4%. The specificity was demonstrated by the unique tryptic mapping patterns obtained compared with several other monoclonal antibodies. Robustness was demonstrated by the relative insensitivity of the tryptic map to small deliberate changes in key method parameters. Excessive relative peak area variability observed for one peak (RSD 52%) was traced to adsorption to glass autosampler vials. This variability was substantially reduced (RSD 11%) by substituting polypropylene autosampler vials. The data demonstrate that this method may be applicable to a wide range of pharmaceutically relevant monoclonal antibodies.
Kannan
K
K
Department of Quality Control Clinical Development, Genentech Inc, South San Francisco, CA 94080-4990, USA.
Mulkerrin
M G
MG
Zhang
M
M
Gray
R
R
Steinharter
T
T
Sewerin
K
K
Baffi
R
R
Harris
R
R
Karunatilake
C
C
D000911:Antibodies, Monoclonal / Q000032:analysis*; D002021:Buffers; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D010084:Oxidation-Reduction; D010449:Peptide Mapping; D011993:Recombinant Fusion Proteins / Q000032:analysis*; D015203:Reproducibility of Results; D014108:Tosylphenylalanyl Chloromethyl Ketone; D014357:Trypsin
D000911:Antibodies, Monoclonal; D002021:Buffers; D011993:Recombinant Fusion Proteins; D014108:Tosylphenylalanyl Chloromethyl Ketone; D014357:Trypsin